Trospium Chloride XR in Obese Female Patients With Overactive Bladder

Summary

This study evaluated the effectiveness of trospium chloride extended release (XR) in obese female patients with overactive bladder (OAB). Patients received either placebo and trospium chloride XR or placebo only. The study assessed the change from baseline in urinary frequency, urgency, and incontinence for trospium chloride XR versus a placebo-pill. The study was 14 weeks in duration.

Timeline

Start

2009-07

Primary completion

2011-12

Completion

2011-12

Drugs

Indications